See All Slides - tctmd.com

Slides

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Cangrelor II: New Data from the FDA Advisory Board Panel

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux, Robert A. Harrington

September 15, 2014

Presentation TCT 2014

Clinician Perspective

Presenter: James A. Goldstein

September 15, 2014

Presentation TCT 2014

Basic Bifurcation Guidance: When to Start with a Provisional 2-Stent Technique (with Case Examples)

Presenter: Yves R. Louvard, Bernhard Reimers, Elvin Kedhi, Thierry Lefevre

September 15, 2014

Presentation TCT 2014

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Presenter: Matthew G. Hillebrenner, Martin B. Leon, Aaron V. Kaplan, William H. Maisel

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Presentation TCT 2014

IVUS Assessment of ACS and Vulnerable Plaque: Review of PROSPECT, VIVA, and ATHEREMO-IVUS and New Data on the Interpretation of Greyscale Plaque Morphology

Presenter: Hector M. Garcia-Garcia, John McB. Hodgson, Robert J. Russo, Soo-Jin Kang

September 15, 2014

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Presentation TCT 2014

Cangrelor I: Data Essentials from the Champion Trials

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux, Deepak L. Bhatt

September 15, 2014

Presentation TCT 2014

Physicist Perspective

Presenter: Stephen Balter

September 15, 2014

Advertisement

Slides

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Cangrelor II: New Data from the FDA Advisory Board Panel

Clinician Perspective

Basic Bifurcation Guidance: When to Start with a Provisional 2-Stent Technique (with Case Examples)

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Enhanced Effects of Primed Peripheral Monocytes

IVUS Assessment of ACS and Vulnerable Plaque: Review of PROSPECT, VIVA, and ATHEREMO-IVUS and New Data on the Interpretation of Greyscale Plaque Morphology

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Cangrelor I: Data Essentials from the Champion Trials

Physicist Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content